Filing Details
- Accession Number:
- 0001127602-16-038283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-28 18:09:48
- Reporting Period:
- 2016-01-26
- Filing Date:
- 2016-01-28
- Accepted Time:
- 2016-01-28 18:09:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-01-26 | 20,000 | $36.30 | 453,423 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-01-26 | 3,134 | $169.97 | 450,289 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-26 | 4,735 | $170.84 | 445,554 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-26 | 5,891 | $172.05 | 439,663 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-26 | 5,940 | $172.85 | 433,723 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-01-26 | 300 | $174.01 | 433,423 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2016-01-26 | 20,000 | $0.00 | 20,000 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 175,000 | 2010-02-28 | 2020-01-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,000 | Indirect | By Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 3,134 shares sold ranging from $169.30 to $170.23 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 4,735 shares sold ranging from $170.30 to $171.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 5,891 shares sold ranging from $171.43 to $172.41 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 5,940 shares sold ranging from $172.45 to $173.28 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $174.00 to $174.03 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
